Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Total Current Liabilities (2016 - 2025)

Anaptysbio filings provide 10 years of Total Current Liabilities readings, the most recent being $38.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 14.98% year-over-year to $38.6 million, compared with a TTM value of $38.6 million through Dec 2025, down 14.98%, and an annual FY2025 reading of $38.6 million, down 14.98% over the prior year.
  • Total Current Liabilities hit $38.6 million in Q4 2025 for Anaptysbio, up from $38.1 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $45.4 million in Q4 2024, with the low at $14.5 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $35.7 million (2023), compared with a mean of $31.6 million.
  • The sharpest move saw Total Current Liabilities plummeted 37.74% in 2021, then soared 109.51% in 2023.
  • Year by year, Total Current Liabilities stood at $16.1 million in 2021, then surged by 61.84% to $26.1 million in 2022, then surged by 43.71% to $37.4 million in 2023, then grew by 21.33% to $45.4 million in 2024, then fell by 14.98% to $38.6 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $38.6 million, $38.1 million, and $35.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.